摘要:
The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds.
摘要:
A charging cable, used for charging an electric storage device in an electric vehicle from an external power supply, controls a usage history of the charging cable by a CCID, displays a warning on an external monitor, and regulates charging when a service life limit of the charging cable has been exceeded.
摘要:
The present invention provides a semiconductor designing apparatus realizing dispersed power consumption timings without causing a setup violation and a hold violation. An STA unit calculates a setup slack as a margin of setup time of a flip-flop on the basis of a present design value of a clock latency of the flip-flop. Based on the calculated setup slack, an HSLD unit adjusts the clock latency of the flip-flop so as to be advanced more than a present design value without causing a timing violation. When a peak equal to or larger than a threshold value remains in the number of synchs in a clock latency distribution as a result of the latency control of the HSLD unit, a PAS unit smoothes the clock latency of the flip-flop without causing a timing violation on the basis of the timing information recalculated by the HSLD unit.
摘要:
This invention provides new compounds, pharmaceutical compositions and diagnostic kits comprising such compounds, and methods of using such compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, inhibiting angiogenesis, effecting a TGF-β activity or a neuronal activity, and treating a glutamate abnormality, a compulsive disorder, neuropathy, pain, a prostate disease, cancer, Huntington's disease, diabetes, a retinal disorder or glaucoma.
摘要:
This invention relates to new compounds, pharmaceutical compositions and diagnostic kits comprising such compounds, and methods of using such compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALAdase levels are altered, effecting neuronal activity, effecting TGF-β activity, inhibiting angiogenesis, and treating glutamate abnormalities, neuropathy, pain, compulsive disorders, prostate diseases, cancers and glaucoma.
摘要:
The present invention relates to new thiolalkyl benzoic acids, pharmaceutical compositions and diagnostic kits comprising such compounds, and methods of using such compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, effecting neuronal activity, effecting TGF-β activity, inhibiting angiogenesis, and treating glutamate abnormalities, neuropathy, pain, compulsive disorders, prostate diseases, cancers, glaucoma, retinal disorders, and cancer.
摘要:
An electromagnetic interference shielded connector includes a plurality of electric wires, which has connecting parts at ends of the electric wires respectively; a connector housing, which contains the electric wires and the connecting parts; and a metallic shielding shell. The metallic shielding shell includes a cylindrical electric-wire drawn-out portion, through which the electric wires are drawn out; and a terminal drawn-out portion, from which the connecting parts are protruded. The connector housing is formed by an entire molding so as to fill a resin inside of the metallic shielding shell in a state that the electric wires are inserted through the electric-wire drawn-out portion and the connecting parts are drawn out through the terminal drawn-out portion.